Ticker brief

INO INOVIO PHARMACEUTICALS INC

Consumer, Non-cyclical · Biotechnology

last close
$0.8971
1 day
+6.9%
14 days
-22.0%
mkt cap
$100.4M
signals 14d
8
authors 14d
4
crowd 14d
+0.1σ
Options inteloptions-surface reads · latest available day per source
metricreadingcontext
IV — ATM 30d109%IV/HV 1.26× (as of 2024-11-19)
Skew — 25Δ RR 30d-0.04125Δ call IV − put IV
OI alarmquietlast alarm 2026-05-11 (z=9.0)
Sentiment — last 14 days
daily mean sentiment, 2026-10-06 → 2026-10-16 · now +0.00 (−1 bearish … +1 bullish)
Who spoke4
authorgradetrader scoresignalsmean sent
@BiopharmIQB·3+0.00
@BPharmCatalystC·2+0.00
@RevSharkB+1.922+0.00
@artinmemesC+1.041+0.30
Recent signals8of 8 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-10-16@BiopharmIQ+0.00The tweet lists upcoming October FDA decision dates for three companies.-9.4%
2026-10-16@BPharmCatalyst+0.00Publishes a biotech watchlist for catalysts expected in mid-winter 2026.-9.4%
2026-10-16@RevShark+0.00Buy PGEN aggressively if it sells off in reaction to INO. — States a conditional intention to buy PGEN aggressively on an INO-driven selloff.-9.4%
2026-10-16@RevShark+0.00Look for additional PGEN entries around upcoming INO news. — Explicitly seeks additional PGEN entries while identifying INO news as the near-term catalyst.-9.4%
2026-10-12@BiopharmIQ+0.00Lists explicit October FDA decision dates for three drug candidates.-18.8%
2026-10-10@artinmemes+0.30Presents a U.S.-stock basket that could benefit from rising concern about plague in Russia.-22.0%
2026-10-09@BPharmCatalyst+0.00Six-month watchlist of upcoming PDUFA catalyst decisions; ticker list capped at six.-22.0%
2026-10-06@BiopharmIQ+0.00Provides explicit October PDUFA dates for five drug candidates across four issuers.-20.6%

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.